X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (7296) 7296
Publication (519) 519
Book Review (75) 75
Newsletter (51) 51
Book Chapter (8) 8
Conference Proceeding (7) 7
Dissertation (7) 7
Book / eBook (1) 1
Magazine Article (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5753) 5753
oncology (5087) 5087
cisplatin (4457) 4457
chemotherapy (4271) 4271
index medicus (3956) 3956
female (3743) 3743
male (3132) 3132
middle aged (3091) 3091
aged (3035) 3035
cancer (2949) 2949
antineoplastic combined chemotherapy protocols - therapeutic use (2888) 2888
gemcitabine (2413) 2413
adult (2344) 2344
lung neoplasms - drug therapy (2111) 2111
treatment outcome (1943) 1943
deoxycytidine - analogs & derivatives (1916) 1916
cisplatin - administration & dosage (1910) 1910
carcinoma, non-small-cell lung - drug therapy (1880) 1880
deoxycytidine - administration & dosage (1546) 1546
care and treatment (1361) 1361
carboplatin (1252) 1252
neoplasm staging (1243) 1243
lung neoplasms - pathology (1227) 1227
paclitaxel (1198) 1198
survival (1192) 1192
antineoplastic combined chemotherapy protocols - adverse effects (1180) 1180
carcinoma (1151) 1151
research (1044) 1044
carcinoma, non-small-cell lung - pathology (1015) 1015
antineoplastic agents - therapeutic use (995) 995
aged, 80 and over (993) 993
trial (980) 980
prognosis (972) 972
lung cancer (967) 967
medicine & public health (962) 962
lung cancer, non-small cell (943) 943
disease-free survival (914) 914
survival rate (904) 904
combination (874) 874
survival analysis (835) 835
therapy (835) 835
pharmacology & pharmacy (830) 830
phase-iii trial (830) 830
metastasis (798) 798
phase-ii trial (768) 768
respiratory system (766) 766
non-small cell lung cancer (750) 750
analysis (722) 722
retrospective studies (716) 716
docetaxel (705) 705
drug therapy (685) 685
hematology, oncology and palliative medicine (681) 681
carboplatin - administration & dosage (676) 676
cancer therapies (661) 661
lung neoplasms - mortality (657) 657
radiotherapy (651) 651
antineoplastic agents (645) 645
clinical trials (645) 645
antineoplastic combined chemotherapy protocols - administration & dosage (628) 628
paclitaxel - administration & dosage (627) 627
tumors (626) 626
cisplatin - therapeutic use (623) 623
vinorelbine (606) 606
antimitotic agents (593) 593
carcinoma, non-small-cell lung - mortality (593) 593
combined modality therapy (593) 593
health aspects (591) 591
drug administration schedule (590) 590
randomized-trial (589) 589
bladder cancer (548) 548
phase-ii (545) 545
cisplatin - adverse effects (544) 544
deoxycytidine - adverse effects (541) 541
surgery (519) 519
patients (510) 510
cancer research (508) 508
cell lung-cancer (489) 489
cell line, tumor (472) 472
urinary bladder neoplasms - drug therapy (467) 467
oncology, experimental (465) 465
apoptosis (462) 462
animals (460) 460
phase-iii (456) 456
doxorubicin (453) 453
toxicity (442) 442
chemotherapy, adjuvant (441) 441
multicenter (441) 441
pemetrexed (439) 439
follow-up studies (437) 437
antineoplastic agents - administration & dosage (435) 435
deoxycytidine - therapeutic use (429) 429
bevacizumab (425) 425
vinblastine - analogs & derivatives (423) 423
patient outcomes (419) 419
vinblastine - administration & dosage (419) 419
adenocarcinoma (418) 418
ovarian cancer (418) 418
adjuvant chemotherapy (412) 412
plus cisplatin (410) 410
adenocarcinoma - drug therapy (408) 408
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7207) 7207
German (47) 47
French (38) 38
Japanese (25) 25
Chinese (21) 21
Spanish (11) 11
Italian (2) 2
Polish (2) 2
Turkish (2) 2
Bosnian (1) 1
Korean (1) 1
Persian (1) 1
Portuguese (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 04/2010, Volume 362, Issue 14, pp. 1273 - 1281
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 7, pp. 763 - 774
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2006, Volume 24, Issue 24, pp. 3946 - 3952
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 06/2007, Volume 25, Issue 16, pp. 2212 - 2217
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 4, pp. 436 - 446
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 2, pp. 213 - 222
Summary Background Afatinib—an oral irreversible ErbB family blocker—improves progression-free survival compared with pemetrexed and cisplatin for first-line... 
Hematology, Oncology and Palliative Medicine | GEFITINIB | MULTICENTER | SOLID TUMORS | ONCOLOGY | ADENOCARCINOMA | CLINICAL-TRIALS | INHIBITOR | ERBB FAMILY BLOCKER | CHEMOTHERAPY | ERLOTINIB | Lung Neoplasms - drug therapy | Lung Neoplasms - ethnology | Receptor, Epidermal Growth Factor - genetics | Lung Neoplasms - mortality | Humans | Middle Aged | Thailand - epidemiology | Asian Continental Ancestry Group - genetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lung Neoplasms - pathology | Male | Protein Kinase Inhibitors - adverse effects | Cisplatin - administration & dosage | Time Factors | Female | Odds Ratio | Republic of Korea - epidemiology | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Deoxycytidine - administration & dosage | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Carcinoma, Non-Small-Cell Lung - ethnology | Linear Models | Logistic Models | Treatment Outcome | China - epidemiology | Carcinoma, Non-Small-Cell Lung - mortality | Disease Progression | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Quinazolines - therapeutic use | Intention to Treat Analysis | Quinazolines - adverse effects | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Neoplasm Staging | Deoxycytidine - analogs & derivatives | Antimitotic agents | Medical colleges | Care and treatment | Chemotherapy | Product development | Lung cancer, Non-small cell | Antineoplastic agents | Tumors | Cancer | Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2008, Volume 26, Issue 21, pp. 3543 - 3551
Journal Article
Cancer, ISSN 0008-543X, 08/2015, Volume 121, Issue 15, pp. 2586 - 2593
BACKGROUND Gemcitabine plus cisplatin (GC) has been adopted as a neoadjuvant regimen for muscle‐invasive bladder cancer despite the lack of Level I evidence in... 
neoadjuvant | gemcitabine plus cisplatin | vinblastine | bladder cancer | muscle invasion | methotrexate | doxorubicin | cisplatin | plus cisplatin | SURVIVAL | MULTICENTER | MANAGEMENT | PROPENSITY SCORE | CHEMOTHERAPY | ONCOLOGY | ACCELERATED METHOTREXATE | CYSTECTOMY | RETROSPECTIVE ANALYSIS | ADVANCED UROTHELIAL CARCINOMA | CLINICAL-OUTCOMES | Carcinoma, Transitional Cell - mortality | Doxorubicin - therapeutic use | Humans | Middle Aged | Male | Methotrexate - therapeutic use | Vinblastine - therapeutic use | Cisplatin - administration & dosage | Muscle Neoplasms - mortality | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Adult | Female | Neoadjuvant Therapy | Retrospective Studies | Muscle Neoplasms - drug therapy | Multicenter Studies as Topic - statistics & numerical data | Urinary Bladder Neoplasms - mortality | Neoplasm Invasiveness | Deoxycytidine - administration & dosage | Muscle Neoplasms - secondary | Treatment Outcome | Urinary Bladder Neoplasms - drug therapy | Carcinoma, Transitional Cell - pathology | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Carcinoma, Transitional Cell - drug therapy | Aged | Deoxycytidine - analogs & derivatives | Neoadjuvant therapy | Care and treatment | Usage | Dosage and administration | Diagnosis | Bladder cancer | Doxorubicin | Cisplatin
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2008, Volume 26, Issue 22, pp. 3695 - 3701
Journal Article